Surgical treatment strategies for multifocal hepatocellular carcinomas  

作　　者：Xuehai Jia Anque Liao Li Jiang 

机构地区：[1]Division of Liver Surgery,Department of General Surgery,West China Hospital of Sichuan University,Chengdu,China [2]Department of Operation Center,West China Hospital/West China School of Nursing,Sichuan University,Chengdu,China

出　　处：《Hepatobiliary Surgery and Nutrition》2024年第6期1071-1076,共6页肝胆外科与营养(英文)

基　　金：supported by the National Natural Science Foundation of China(No.82470652 to L.J.);Sichuan Province Key Research and Development Project(No.2019YFS0203 to L.J.);Key Clinical Research Incubation Project of West China Hospital of Sichuan University(No.2020HXFH028 to L.J.);Key R&D Support Plan of Chengdu Science and Technology Bureau(No.2021-YF05-00703-SN to L.J.);Sichuan Province Key Research and Development Project(No.2022YFS0090 to L.J.);Sichuan Natural Science Foundation project(No.24NSFSC0237 to L.J.).

摘　　要：The multifocality of hepatocellular carcinoma(HCC)still represents considerable challenges,with generally poorer outcomes compared to the single HCC(SH).According to the Barcelona Clinic Liver Cancer(BCLC)guideline,only patients with early-stage multifocal HCCs(MHs)(≤3 nodules and each≤3 cm)or those meeting the extended liver transplant criteria are recommended to undergo liver transplantation(LT)or ablation[e.g.,radiofrequency ablation(RFA)or microwave ablation(MWA)].

关 键 词：MULTIFOCAL HEPATOCELLULAR LIVER 

分 类 号：R73[医药卫生—肿瘤]